Table 8.
Renal composite endpoint (HR, 95%CI, P ) | ||
Fitting model by two-piecewise Cox regression | ||
Inflection point of ALB | 4.3 g/dL | |
≤ 4.3 g/dL | 0.42 (0.32, 0.56) | < 0.001 |
> 4.3 g/dL | 6.11 (0.98, 38.22) | 0.05 |
P for log-likelihood ratio test | < 0.05 | |
Renal function decline (β, 95%CI, P) | ||
Fitting model by two-piecewise linear regression | ||
Inflection point of ALB | 4.1 g/dL | |
≤ 4.1 g/dL | -2.79 (-3.62, -1.96) | < 0.001 |
> 4.1 g/dL | 0.02 (-1.79, 1.84) | 0.98 |
P for log-likelihood ratio test | < 0.05 |
We adjusted age, BMI, gender, SBP, diabetes, hypertension, history of CVD, eGFR, UPCR, ALB, use of RAAS inhibitor, urinary occult blood, use of calcium channel blocker, and use of diuretics
HR Hazard ratios, CI Confidence interval